NIH-funded research NIH-funded research

Combining therapies to help Veterans with PTSD and suicidal thoughts

Official title: A Hybrid Effectiveness-Implementation Trial of Treatments for Veterans with PTSD at Elevated Acute Risk for Suicide

Funded at VA Puget Sound Healthcare System · NIH-10907444 · Data updated 2026-11-12

This study is looking at a new way to help Veterans with PTSD who are at risk for suicide by testing a combination of two therapies to see if they work better than the usual care, and it aims to find out how well these therapies can be used in Veterans Affairs hospitals.

More Suicide research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Puget Sound Healthcare System
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2027
Funding year2025
NIH project number5I01HX003676-02
Project IDNIH-10907444 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are Veterans diagnosed with PTSD who are currently experiencing elevated acute risk for suicide.

Less likely to help

Patients who do not have PTSD or are not at risk for suicide may not benefit from this research.

What this research studies

This research investigates a new treatment approach for Veterans suffering from PTSD who are at high risk for suicide. It aims to compare the effectiveness of a combined therapy that includes Dialectical Behavior Therapy (DBT) and Prolonged Exposure therapy against the current standard care. The study will also explore how well these therapies can be implemented within the Veterans Affairs healthcare system. By focusing on a population that has historically been excluded from treatment trials, this research seeks to provide evidence-based guidance for clinicians.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatment options for Veterans with PTSD, significantly reducing their risk of suicide.

How similar studies have gone: Previous research has shown promise in using combined therapy approaches for PTSD, but this specific combination for high-risk individuals is relatively novel.

Where this research is happening

  • VA Puget Sound Healthcare System
    Seattle, United States
    Active

Researchers

  • Principal investigator: Harned, Melanie — VA Puget Sound Healthcare System
  • Study coordinator: Harned, Melanie

Related research

Other NIH-funded projects on the same topics.

  • Comparing two PTSD treatments for Veterans at high suicide risk

    This project compares a combined Dialectical Behavior Therapy plus Prolonged Exposure approach to standard Prolonged Exposure with suicide risk management for Veterans with PTSD who are at high immediate risk of suicide.

    NIH research VA Puget Sound Healthcare System · Seattle, United States · NIH-11222673

  • Evaluating a new therapy for individuals with PTSD and borderline personality disorder.

    This study is testing a new therapy that combines talking therapy for PTSD with special support for managing suicide risk, designed for people who have both PTSD and borderline personality disorder, to see if it helps them feel better in everyday life.

    NIH research Palo Alto University · Palo Alto, United States · NIH-10775720

  • Understanding Invisible Suicide Risks in Youth: A National Study in Guyana

    A nationwide study in Guyana aims to learn about hidden factors that contribute to suicide risk among young people so we can prevent tragedy.

    NIH research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · New York, United States · NIH-11617664

  • Understanding how PTSD affects self-control and brain function

    Researchers are studying how PTSD changes the brain’s control over thoughts and actions, and how this might affect Veterans’ daily lives and responses to treatment.

    NIH research VA Boston Health Care System · Boston, United States · NIH-11617299

  • Mobile safety planning for at-risk young adults

    A digital, text-based safety planning program for young adults (ages 18–24) to help prevent suicide and stay connected to support.

    NIH research Northwestern University · Chicago, United States · NIH-11606617

  • Ketamine to boost fear extinction and memory on PTSD patients

    A study testing whether ketamine can help people with PTSD better relearn and forget fear when given in a guided treatment plan.

    NIH research Yale University · New Haven, United States · NIH-11592530

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.